11/2/2012

A report from Global Industry Analysts projects that the global nuclear medicine market will be valued at $2.46 billion by 2018. The major drivers for this growth include more cases of neurological and cardiac diseases, advances in nuclear medicine devices and increased adoption of hybrid modalities such as SPECT/CT and PET/CT, the report said.

Full Story:
PR Web

Related Summaries